Back to School: How biopharma can reboot drug development. Access exclusive analysis here

ProStrakan raises L22 million

ProStrakan (Galashiels, UK) raised L22 million ($39.6 million) in a

Read the full 105 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE